These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10769437)

  • 21. Glucocorticoid-induced osteoporosis: is the bone density decrease the only explanation?
    Lespessailles E; Poupon S; Adriambelosoa N; Pothuaud L; Siroux V; Bouillon S; Benhamou CL
    Joint Bone Spine; 2000; 67(2):119-26. PubMed ID: 10769104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose glucocorticoids in early rheumatoid arthritis: discordant effects on bone mineral density and fractures?
    van Everdingen AA; Siewertsz van Reesema DR; Jacobs JW; Bijlsma JW
    Clin Exp Rheumatol; 2003; 21(2):155-60. PubMed ID: 12747268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of alfacalcidol on mineral density of bone tissue in patients with rheumatoid arthritis].
    Gukasian DA; Nasonov EL; Balabanova RM; Smirnov AV; Vlasova IS
    Klin Med (Mosk); 2001; 79(9):47-50. PubMed ID: 11641938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Osteoporosis in rheumatoid arthritis--significance of alfacalcidol in prevention and therapy].
    Schacht E
    Z Rheumatol; 2000; 59 Suppl 1():10-20. PubMed ID: 10769429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial.
    Lane NE; Sanchez S; Modin GW; Genant HK; Pierini E; Arnaud CD
    J Bone Miner Res; 2000 May; 15(5):944-51. PubMed ID: 10804025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of 4-year treatment with once-weekly clodronate on prevention of corticosteroid-induced bone loss and fractures in patients with arthritis: evaluation with dual-energy X-ray absorptiometry and quantitative ultrasound.
    Frediani B; Falsetti P; Baldi F; Acciai C; Filippou G; Marcolongo R
    Bone; 2003 Oct; 33(4):575-81. PubMed ID: 14555261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Raloxifene for prevention of glucocorticoid-induced bone loss: a 12-month randomised double-blinded placebo-controlled trial.
    Mok CC; Ying KY; To CH; Ho LY; Yu KL; Lee HK; Ma KM
    Ann Rheum Dis; 2011 May; 70(5):778-84. PubMed ID: 21187295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-term effect of 1 alpha-hydroxyvitamin D, calcium and thiazide administration on glucocorticoid-induced osteoporosis].
    Yamada H
    Nihon Naibunpi Gakkai Zasshi; 1989 Jun; 65(6):603-14. PubMed ID: 2792461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy.
    Fujita T; Satomura A; Hidaka M; Ohsawa I; Endo M; Ohi H
    Calcif Tissue Int; 2000 Mar; 66(3):195-9. PubMed ID: 10666494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the efficacy of etidronate therapy in preventing glucocorticoid-induced bone loss in patients with inflammatory rheumatic diseases. A randomized study.
    Cortet B; Hachulla E; Barton I; Bonvoisin B; Roux C
    Rev Rhum Engl Ed; 1999 Apr; 66(4):214-9. PubMed ID: 10339777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of calcium and alfacalcidol supplement in the prevention of osteopenia after kidney transplantation.
    Berczi C; Asztalos L; Kincses Z; Balogh A; Löcsey L; Balázs G; Lukács G
    Osteoporos Int; 2003 Jun; 14(5):412-7. PubMed ID: 12730763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis.
    de Nijs RN; Jacobs JW; Lems WF; Laan RF; Algra A; Huisman AM; Buskens E; de Laet CE; Oostveen AC; Geusens PP; Bruyn GA; Dijkmans BA; Bijlsma JW;
    N Engl J Med; 2006 Aug; 355(7):675-84. PubMed ID: 16914703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term oral corticosteroid treatment.
    Pitt P; Li F; Todd P; Webber D; Pack S; Moniz C
    Thorax; 1998 May; 53(5):351-6. PubMed ID: 9708225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
    Lems WF; Lodder MC; Lips P; Bijlsma JW; Geusens P; Schrameijer N; van de Ven CM; Dijkmans BA
    Osteoporos Int; 2006; 17(5):716-23. PubMed ID: 16463007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dynamics of bone biochemical markers in nephrotic children treated with prednisone and metabolites of vitamin D].
    Wojnar J; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
    Przegl Lek; 2007; 64(9):552-8. PubMed ID: 18510075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone mineral density changes in women with systemic lupus erythematosus.
    Boyanov M; Robeva R; Popivanov P
    Clin Rheumatol; 2003 Oct; 22(4-5):318-23. PubMed ID: 14579164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy of glucocorticoid-induced osteoporosis with alfacalcidol/calcium and vitamin D/calcium].
    Ringe JD; Cöster A; Meng T; Schacht E; Umbach R
    Z Rheumatol; 2000 Jun; 59(3):176-82. PubMed ID: 10929446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of corticosteroid-induced osteoporosis with alendronate in sarcoid patients.
    Gonnelli S; Rottoli P; Cepollaro C; Pondrelli C; Cappiello V; Vagliasindi M; Gennari C
    Calcif Tissue Int; 1997 Nov; 61(5):382-5. PubMed ID: 9351879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of low-dose prednisone on bone metabolism.
    Ton FN; Gunawardene SC; Lee H; Neer RM
    J Bone Miner Res; 2005 Mar; 20(3):464-70. PubMed ID: 15746991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of alendronate or alfacalcidol on bone metabolic indices and bone mineral density in patients with ophthalmologic disease treated with glucocorticoid.
    Ikeda T; Maruyama K; Kaji H; Akagi M
    Mod Rheumatol; 2014 Jul; 24(4):671-6. PubMed ID: 24313921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.